NAGIOS: RODERIC FUNCIONANDO

Bisphosphonates and dental implants: current problems

Repositori DSpace/Manakin

IMPORTANT: Aquest repositori està en una versió antiga des del 3/12/2023. La nova instal.lació está en https://roderic.uv.es/

Bisphosphonates and dental implants: current problems

Mostra el registre parcial de l'element

dc.contributor.author Flichy Fernández,Antonio es
dc.contributor.author Balaguer Martínez,José es
dc.contributor.author Peñarrocha Diago,Miguel es
dc.contributor.author Bagán Sebastián,José Vicente es
dc.date.accessioned 2023-06-22T12:12:39Z
dc.date.available 2023-06-22T12:12:39Z
dc.date.issued 2009 es
dc.identifier.citation Flichy-Fernández AJ, Balaguer-Martínez J, Peñarrocha-Diago M, Bagán JV. Bisphosphonates and dental implants: Current problems. Med Oral Patol Oral Cir Bucal. 2009 July 1;14(7):E355-E360. es
dc.identifier.uri https://hdl.handle.net/10550/88486
dc.description.abstract Osteonecrosis of the jaw has been described in patients taking bisphosphonates after oral surgery procedures, including the placement of dental implants. This review is an update of the relationship between bisphosphonates and dental implants.Results obtained by different authors are compared, contrasting earlier studies where an improvement in implant osseointegration using bisphosphonates was observed, with ones where statistically significant differences were found, and more recent studies disagreeing with the use of bisphosphonates for causing necrosis of the jaw. The differing results obtained between animal studies and the situation observed in humans may be due to a short medication and follow-up period, as well as to the existence of few research studies where dental implants are placed in the oral cavity.Currently, dental implants are contraindicated in patients being treated with intravenous bisphosphonates. In 2007, the American Association of Oral and Maxillofacial Surgeons suggested guidelines for patients treated with oral bisphosphonates, based on the clinical situation of the patient and the length of treatment with the drug, and that greater caution prior and subsequent to surgery should be taken for three years after treatment. All patients treated with bisphosphonates must have the risk of possible loss of implants and the risk of suffering a bony necrosis of the operated jaw explained to them, and give their informed consent prior to dental implant surgery. es
dc.title Bisphosphonates and dental implants: current problems es
dc.type journal article es_ES
dc.subject.unesco UNESCO:CIENCIAS MÉDICAS es
dc.type.hasVersion VoR es_ES
dc.identifier.url http://www.medicinaoral.com/medoralfree01/v14i7/medoralv14i7p355.pdf

Visualització       (321.3Kb)

Aquest element apareix en la col·lecció o col·leccions següent(s)

Mostra el registre parcial de l'element

Cerca a RODERIC

Cerca avançada

Visualitza

Estadístiques